Clinical Trial Update: Investigation Into the Safety and Scar-improvement Efficacy of Intradermal Juvidex Dosed Once or Three Times [Phase 2]

View source ↗

Summary

Phase 2 clinical trial completed evaluating the safety and scar-improvement efficacy of intradermal Juvidex administered once or three times.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Scarring
• Wound Healing

Drugs mentioned

• Juvidex (Mannose-6-Phosphate)

Snippet

Sponsor: Renovo | Conditions: Cicatrix, Wound-healing | Phase 2 | Status: COMPLETED